THC

Tenet Healthcare Corp. 10-Q Summary

Business Context and Reporting Period

This Form 10-Q covers the quarterly period ended February 28, 2002, and the nine-month period ended on the same date. Tenet Healthcare Corporation operates a network of general hospitals and related healthcare facilities. As of the period end, the company operated 116 domestic general hospitals with 28,677 licensed beds. The company has been actively acquiring facilities, purchasing five general hospitals and opening a new joint venture hospital during the nine-month period, while divesting one hospital and three long-term care facilities.

Key Financial Metrics

Margins: Operating margin for the nine-month period was 14.5% (15.5% before impairment charges). EBITDA margin increased to 20.7% for the quarter.

Material Changes vs. Prior Period

• Revenue Growth: Net operating revenues increased 15.1% to $10.175 billion for the nine months ended Feb 28, 2002, compared to $8.844 billion in the prior year. Same-facility net patient revenues rose 11.5% in the quarter.
• Profitability: Operating income increased 20.7% to $1.472 billion. However, reported Net Income decreased slightly to $524 million from $527 million in the prior year due to a significant extraordinary charge.
• Unusual Items: The company recorded $99 million in impairment and other unusual charges (primarily related to hospital closures and asset write-offs) and an $180 million extraordinary charge from the early extinguishment of debt (net of tax benefits).
• Cash Flow: Net cash provided by operating activities surged 59.2% to $1.493 billion, driven by improved collections (accounts receivable days outstanding dropped from 78.5 to 64.0 days) and higher operating margins.
• Debt Reduction: Despite new borrowings, the company reduced its total debt by $573 million since the end of the prior-year quarter through aggressive debt repurchases.

Guidance, Outlook, and Risks

Outlook: Management anticipates continued increases in same-facility inpatient revenue per admission, though at a slower rate than the current fiscal year. The company expects the nursing shortage to remain a primary cost pressure. Capital expenditures for fiscal 2002 are projected at approximately $800 million.

Recent Transactions: Subsequent to the period end, Tenet sold $600 million of new Senior Notes and repurchased $839 million of Senior Subordinated Notes, expecting an additional extraordinary charge of approximately $59 million in the next quarter.

Risks and Contingencies:

• Legal Proceedings: No material developments in previously reported litigation.
• Accounting Changes: The company will adopt SFAS 142 (Goodwill) effective June 1, 2002, which will cease goodwill amortization. Pro forma adjustments show this would have increased net income by $65 million for the nine-month period.
• Regulatory Environment: Ongoing changes in Medicare and Medicaid reimbursement rates and managed care contracting terms.

Investor Verification Checklist

• Debt Restructuring Impact: Verify the full impact of the $180 million extraordinary charge and the subsequent $59 million expected charge on future earnings.
• Goodwill Accounting: Confirm the pro forma impact of the upcoming SFAS 142 adoption on future earnings per share.
• Cash Flow Quality: Review the sustainability of the improved accounts receivable collection metrics (64.0 days) amidst a shift in payor mix toward managed care.
• Share Repurchases: Monitor the execution of the $336 million forward stock purchase agreements and the impact on liquidity.
• Impairment Reserves: Track the utilization of the $102 million liability reserve for exit costs and impairments, with $26 million expected to be paid in the remainder of fiscal 2002.